Predictors of 6 month-mortality following intermediate-high and high risk pulmonary embolism

نویسندگان

چکیده

Abstract Funding Acknowledgements Type of funding sources: None. BACKGROUND Pulmonary embolism (PE) is the third most frequent cardiovascular disease and associated with high mortality, during admission short-term follow-up. Due to Right Ventricular (RV) dysfunction or Hypertension (PH), also because anticoagulation's bleeding complications PE may be first manifestation underlying cancer. Purpose To determine clinical echocardiography characteristics 6 month-mortality patients an intermediate-high admitted in Acute Cardiovascular Care Unit (ACCU). Methods The present study a retrospective analysis 137 risk our ACCU between May-2017 May-2021. Clinical, biochemical echocardiographic variables were analyzed on admission, prior discharge month follow-up period. Mortality was evaluated at months. Univariate logistic used analyze markers mortality. Results majority women 77 (56%), aged 16-90 years. 78 (57%) had hypertension, 64(46%) Dyslipemia, 50(37%) obesity 12 (9%) previous On 76( 56%) consulted for dyspnea 52(38%) syncope. 81 (60%) presented respiratory failure (pO2<60 mmHg), 98(72%) elevated Nt-proBNP (3583 ±4874) 109 (80%) Troponin. 36 (27%) Shock Index>1. echocardiography, 90 (66%) RV (TAPSE≤16mm), 120(89%) dilated (basal RV/LV ratio>1.0) PH was: 44 (36%) Mild, 48 (39%) Moderate 22 (18%) Severe. Regarding treatment received: 85 (62%) Heparin Sodium, 11 (8%) Systemic fibrinolysis, 31 (23%) Catheter-directed therapies 10 (7%) LMWH. During (5%) suffer minor 9 major bleeding. At 101 (82%) improved function 95 (None 62 (54 %), Mild 40 (35%), Severe 2 (2%)). In months follow-up, 13(10%) died, 3(2%) readmitted new 4(3%) New cancer diagnosed 12(9%) patients. (74%) NYHA-I. death (Table 1) significantly increased diabetes (46% vs 16%,p=0.009), those which persisted (50% 8%,p=0.001), case readmission (43% 0.8%,p=0.001) (57% 7%,p=0.001). Variables months-mortality univariate 2) are: Nt-proBNP, Major readmission, cancer, discharge, Dilated-RV moderate severe before discharge. Conclusion sample, due PH, persistence dysfunction, having suffering from short increases death. Although data misestimated low rate events.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Predictors of pulmonary hypertension after intermediate-to-high risk pulmonary embolism.

BACKGROUND Pulmonary embolism (PE) is a common cardiovascular emergency that, when combined with chronic thromboembolic pulmonary hypertension (PH), is associated with high mortality and morbidity. We aimed to determine the incidence of and predisposing factors for the development of PH after a PE episode. METHODS A retrospective study was conducted in 213 patients admitted to an intensive ca...

متن کامل

Pulmonary artery catheter-directed thrombolysis for intermediate high risk acute pulmonary embolism

A case of 60-year-old male with acute pulmonary embolism without hypotension but signs of right ventricular dysfunction and elevated cardiac biomarkers is reported in this study. The patient comes under intermediate high-risk category and was successfully thrombolysed with alteplase infused through pulmonary artery catheter. Catheter-directed thrombolysis (CDT) can be considered as much safer a...

متن کامل

Fixed low-dose ultrasound-assisted catheter-directed thrombolysis for intermediate and high-risk pulmonary embolism.

AIMS No standardized local thrombolysis regimen exists for the treatment of pulmonary embolism (PE). We retrospectively investigated efficacy and safety of fixed low-dose ultrasound-assisted catheter-directed thrombolysis (USAT) for intermediate- and high-risk PE. METHODS AND RESULTS Fifty-two patients (65 ± 14 years) of whom 14 had high-risk PE (troponin positive in all) and 38 intermediate-...

متن کامل

Fibrinolysis for intermediate-risk pulmonary embolism.

To the Editor: In the Pulmonary Embolism Thrombolysis (PEITHO) study (April 10 issue),1 a bolus of unfractionated heparin was withheld from 303 patients because they had just received subcutaneous low-molecular-weight heparin or fondaparinux. Low-molecular-weight heparin in particular has a slow onset of action, taking 4 to 6 hours to reach full effect.2 This delay in the effect of treatment ma...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European heart journal. Acute cardiovascular care

سال: 2023

ISSN: ['2048-8726', '2048-8734']

DOI: https://doi.org/10.1093/ehjacc/zuad036.159